202 related articles for article (PubMed ID: 30693467)
1. Natural killer cell expression of Ki67 is associated with elevated serum IL-15, disease activity and nephritis in systemic lupus erythematosus.
Hudspeth K; Wang S; Wang J; Rahman S; Smith MA; Casey KA; ; Manna Z; Sanjuan M; Kolbeck R; Hasni S; Ettinger R; Siegel RM
Clin Exp Immunol; 2019 May; 196(2):226-236. PubMed ID: 30693467
[TBL] [Abstract][Full Text] [Related]
2. Natural Killer and Natural Killer T Cells in Juvenile Systemic Lupus Erythematosus: Relation to Disease Activity and Progression.
Zahran AM; Abdel-Rahim MH; Elsayh KI; Hassanien MM; Mahran SA; Hetta HF
Arch Immunol Ther Exp (Warsz); 2019 Jun; 67(3):161-169. PubMed ID: 30944972
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic Function and Cytokine Production of Natural Killer Cells and Natural Killer T-Like Cells in Systemic Lupus Erythematosis Regulation with Interleukin-15.
Lin SJ; Kuo ML; Hsiao HS; Lee PT; Lee WI; Chen JY; Huang JL
Mediators Inflamm; 2019; 2019():4236562. PubMed ID: 31049024
[TBL] [Abstract][Full Text] [Related]
4. Effect of Interleukin-15 on CD11b, CD54, and CD62L Expression on Natural Killer Cell and Natural Killer T-Like Cells in Systemic Lupus Erythematosus.
Lin SJ; Chen JY; Kuo ML; Hsiao HS; Lee PT; Huang JL
Mediators Inflamm; 2016; 2016():9675861. PubMed ID: 27847409
[TBL] [Abstract][Full Text] [Related]
5. Increased proportion of CD56bright natural killer cells in active and inactive systemic lupus erythematosus.
Schepis D; Gunnarsson I; Eloranta ML; Lampa J; Jacobson SH; Kärre K; Berg L
Immunology; 2009 Jan; 126(1):140-6. PubMed ID: 18564343
[TBL] [Abstract][Full Text] [Related]
6. Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-γ production in patients with active disease.
Hervier B; Beziat V; Haroche J; Mathian A; Lebon P; Ghillani-Dalbin P; Musset L; Debré P; Amoura Z; Vieillard V
Arthritis Rheum; 2011 Jun; 63(6):1698-706. PubMed ID: 21370226
[TBL] [Abstract][Full Text] [Related]
7. Increased ILT2
Chen N; Dai Y; Li H; Long X; Ke J; Zhang J; Sun H; Gao F; Lin H; Yan Q
Clin Rheumatol; 2023 Nov; 42(11):3113-3121. PubMed ID: 37695380
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the regulatory function of natural killer cells from patients with systemic lupus erythematosus.
Cruz-González DJ; Gómez-Martin D; Layseca-Espinosa E; Baranda L; Abud-Mendoza C; Alcocer-Varela J; González-Amaro R; Monsiváis-Urenda AE
Clin Exp Immunol; 2018 Mar; 191(3):288-300. PubMed ID: 29058308
[TBL] [Abstract][Full Text] [Related]
9. NK cells dysfunction in systemic lupus erythematosus: relation to disease activity.
Henriques A; Teixeira L; Inês L; Carvalheiro T; Gonçalves A; Martinho A; Pais ML; da Silva JA; Paiva A
Clin Rheumatol; 2013 Jun; 32(6):805-13. PubMed ID: 23377197
[TBL] [Abstract][Full Text] [Related]
10. Activation status of CD56
Liu M; Liu J; Zhang X; Xiao Y; Jiang G; Huang X
Clin Rheumatol; 2021 Mar; 40(3):1103-1112. PubMed ID: 32797360
[TBL] [Abstract][Full Text] [Related]
11. Changes of frequency and expression level of CD161 in CD8
Park Y; Lim J; Kim SY; Kwon GC; Koo SH; Kim J
Microbiol Immunol; 2020 Jul; 64(7):532-539. PubMed ID: 32343447
[TBL] [Abstract][Full Text] [Related]
12. Activating and inhibitory receptors on natural killer cells in patients with systemic lupus erythematosis-regulation with interleukin-15.
Lin SJ; Kuo ML; Hsiao HS; Lee PT; Chen JY; Huang JL
PLoS One; 2017; 12(10):e0186223. PubMed ID: 29023581
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of natural killer activating and inhibitory receptors in patients with newly diagnosed systemic lupus erythematosus.
Ye Z; Ma N; Zhao L; Jiang ZY; Jiang YF
Int J Rheum Dis; 2016 Jun; 19(6):613-21. PubMed ID: 24617980
[TBL] [Abstract][Full Text] [Related]
14. Role of IL-24 in NK cell activation and its clinical implication in systemic lupus erythematosus.
Tang Y; Sun X; Wang Y; Luan H; Zhang R; Hu F; Sun X; Li X; Guo J
Clin Rheumatol; 2021 Jul; 40(7):2707-2715. PubMed ID: 33534028
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the CD161-expressing cell quantities and CD161 expression levels in peripheral blood natural killer and T cells of systemic lupus erythematosus patients.
Lin YL; Lin SC
Clin Exp Med; 2017 Feb; 17(1):101-109. PubMed ID: 26590595
[TBL] [Abstract][Full Text] [Related]
16. A subgroup of lupus patients with nephritis, innate T cell activation and low vitamin D is identified by the enhancement of circulating MHC class I-related chain A.
Pérez-Ferro M; Romero-Bueno FI; Serrano Del Castillo C; Mahillo I; Alvear A; Largo R; Herrero-Beaumont G; Sánchez-Pernaute O
Clin Exp Immunol; 2019 Jun; 196(3):336-344. PubMed ID: 30737776
[TBL] [Abstract][Full Text] [Related]
17. Systemic lupus erythematosus immune complexes increase the expression of SLAM family members CD319 (CRACC) and CD229 (LY-9) on plasmacytoid dendritic cells and CD319 on CD56(dim) NK cells.
Hagberg N; Theorell J; Schlums H; Eloranta ML; Bryceson YT; Rönnblom L
J Immunol; 2013 Sep; 191(6):2989-98. PubMed ID: 23956418
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of natural killer cells and of gamma/delta T cells in systemic lupus erythematosus. Does it correlate to autoimmunity and to laboratory indices of disease activity?
Riccieri V; Spadaro A; Parisi G; Taccari E; Moretti T; Bernardini G; Favaroni M; Strom R
Lupus; 2000; 9(5):333-7. PubMed ID: 10878724
[TBL] [Abstract][Full Text] [Related]
19. CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus.
Patschan S; Dolff S; Kribben A; Dürig J; Patschan D; Wilde B; Specker C; Philipp T; Witzke O
Clin Exp Immunol; 2006 Aug; 145(2):235-42. PubMed ID: 16879242
[TBL] [Abstract][Full Text] [Related]
20. Increased oxidative stress contributes to impaired peripheral CD56
Lu Z; Tian Y; Bai Z; Liu J; Zhang Y; Qi J; Jin M; Zhu J; Li X
Arthritis Res Ther; 2022 Feb; 24(1):48. PubMed ID: 35172900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
